BioAge Labs, Inc.
BIOA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709941
In the last 90 days, BioAge Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.
Holders of 5% or more of BIOA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of BioAge Labs, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Fortney Kristen | 13G/A | 7.20%2.70M shares | – | Feb 13, 20261 filing | Feb 13, 2026 | SEC |
| Cormorant Asset Management, LP | 13G/A | 5.38%2.39M shares | −1.13 ppfrom 6.51% | Feb 14, 20255 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G | 5.03%2.24M shares | New | Apr 27, 20261 filing | Apr 27, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on BioAge Labs, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20262:01 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 5.38%2.39M shares | −1.13 ppfrom 6.51% | Jun 30, 2026 | SEC |
| May 15, 20264:15 PM ET | Khosla Ventures VI, L.P.and 5 others | 13G/A | 4.00%1.80M shares | –Below 5% | May 15, 2026 | SEC |
| May 15, 20261:18 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 6.51%2.89M shares | +0.82 ppfrom 5.69% | Mar 31, 2026 | SEC |
| Apr 27, 20264:12 PM ET | BlackRock, Inc. | 13G | 5.03%2.24M shares | New | Mar 31, 2026 | SEC |
| Feb 17, 20266:23 PM ET | ADAR1 Capital Management, LLCand 1 other | 13G/A | 0.40%135.6K shares | −5.00 ppfrom 5.40%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20263:02 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 5.69%2.04M shares | −0.28 ppfrom 5.97% | Dec 31, 2025 | SEC |
| Feb 13, 20264:18 PM ET | Fortney Kristen | 13G/A | 7.20%2.70M shares | – | Dec 31, 2025 | SEC |
| Aug 14, 20258:07 PM ET | ADAR1 Capital Management, LLCand 1 other | 13G | 5.40%1.94M shares | New | Jun 30, 2025 | SEC |
| Aug 14, 20253:01 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 5.97%2.14M shares | −1.37 ppfrom 7.34% | Jun 30, 2025 | SEC |
| Feb 14, 20256:27 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 3.70%1.31M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20253:00 PM ET | Cormorant Asset Management, LPand 1 other | 13G | 7.34%2.63M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell BioAge Labs, Inc. shares.
No Form 144 notices for BioAge Labs, Inc. are on file.